Better Therapeutics (NASDAQ: BTTX) is a prescription digital therapeutics company developing a novel form of cognitive behavioral therapy (CBT) to address the root causes of cardiometabolic diseases while lowering healthcare costs. The CBT designed to enable changes in the brain’s neural pathways in order to effect lasting changes in behavior. The company has developed a proprietary platform for developing FDA-regulated, software-based solutions for type 2 diabetes, heart disease, and other conditions . . .

Get GEN Edge Today!

See More on the Edge

Continue reading this article and more
with a GEN Edge subscription

Start Your 30-Day Free Trial Now

Log In Join GEN Edge